Comparative Effect of Aspirin, Meloxicam and Terminalia catappa Leaf Extract on Serum Levels of Some Inflammatory Markers in Alloxan Induced Diabetic Rats

References (31)

1. 1 Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance [DOI]
2. 2 C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus [DOI]
3. 3 A new approach to practical acute toxicity testing [DOI]
4. 4 Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans [DOI]
5. 5 Metformin: From Mechanisms of Action to Therapies [DOI]
6. 6 The Tumor Necrosis Factor Ligand and Receptor Families [DOI]
7. 7 A Meta-Analysis of Cytokines in Alzheimer's Disease [DOI]
8. 8 Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes [DOI]
9. 9 Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects [DOI]
10. 10 Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study [DOI]
11. 11 General aspects of diabetes mellitus [DOI]
12. 12 C-reactive protein: A critical review [DOI]
13. 13 Present status and strategy of NSAIDs-induced small bowel injury [DOI]
14. 14 Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID‐enteropathy in the rat [DOI]
15. 15 Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications [DOI]
16. 16 Long-Term Effects of Nonsteroidal Anti-Inflammatory Drugs and Cyclooxygenase-2 Selective Agents on the Small Bowel: A Cross-Sectional Capsule Enteroscopy Study [DOI]
17. 17 Animals models for studying diabetes mellitus.
18. 18 15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation [DOI]
19. 19 Evaluation of the Antioxidant Activity of Environmental Plants: Activity of the Leaf Extracts from Seashore Plants [DOI]
20. 20 Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus [DOI]
21. 21 Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications [DOI]
22. 22 Insulin Inhibits NFκB and MCP-1 Expression in Human Aortic Endothelial Cells [DOI]
23. 23 COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin [DOI]
24. 24 Preadministration of High-Dose Salicylates, Suppressors of NF-κB Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy [DOI]
25. 25 Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy [DOI]
26. 26 ANTI-DIABETIC ACTIVITY OF TERMINALIA CATAPPA LINN. LEAF EXTRACTS IN ALLOXAN-INDUCED DIABETIC RATS
27. 27 Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations [DOI]
28. 28 Molecular genetics, structure, and function of C-reactive protein [DOI]
29. 29 EVALUATION OF MECHANISM OF ANTI-DIABETIC ACTIVITY OF TERMINALIA CHEBULA ON ALLOXAN AND ADRENALINE INDUCED DIABETIC ALBINO RATS
30. 30 Effect of aqueous extract of Terminalia catappa leaves on the glycaemia of rabbits
31. 31 Meloxicam-induced enteropathy of the small bowel [DOI]

Cited by 11

Showing 3 of 11 known citations — external sources report more than can currently be individually listed.

Related research

• Herbal Approach towards the Cure of Diabetes Mellitus— A Review — shares topic coverage
• Hematological Indices in Alloxan-Induced Diabetic Rats: Effect of Supplementation with the Antioxidant Dimethyl Sulfoxide — shares topic coverage
• Analysis of Risk Factors among Diabetic Patients Visiting Diabetic Research Clinic at Nishtar Hospital Multan-Pakistan — shares topic coverage
• Prevalence of Hypertension among Diabetic Patients in Benghazi: A Study of Associated Factors — shares topic coverage
• Visfatin Level in Diabetic and Non-diabetic Chronic Kidney Diseases — shares topic coverage